Skip to main content

Books in Pharmacology

Elsevier's Pharmacology collection studies how drugs interact with biological systems to improve health and treat disease. It covers pharmacodynamics, exploring drug effects on biology, and pharmacokinetics, studying how the body affects drugs. Branches like Pharmacogenetics. Essential for pharmacologists, this collection offers invaluable insights into drug interactions, efficacy, and safety, crucial for advancing drug development and improving patient outcomes.

    • Farmacología humana

      • 7th Edition
      • May 15, 2025
      • Jesús Flórez Beledo + 2 more
      • Spanish
      • Hardback
        9 7 8 8 4 1 3 8 2 7 6 5 0
      • eBook
        9 7 8 8 4 1 3 8 2 9 7 4 6
      La séptima edición de "Farmacología humana", obra de referencia de la especialidad en habla hispana, ofrece un texto exhaustivo y plenamente actualizado, guiado por la claridad expositiva y combinando el conocimiento teórico con la práctica clínica. Se han mantenido y reforzado los capítulos que abordan los principios básicos de la ciencia farmacológica y se han reflejado todas las novedades acontecidas desde la última edición y se ha incluido un nuevo capítulo dedicado a las "Terapias antoneoplásicas dirigidas". Otra novedad a destacar es la incorporación de nuevos colaboradores que junto con los ya tradicionales aúnan experiencia y frescura a esta magnífica obra.
    • The Science of Pharmacology

      • 1st Edition
      • October 15, 2025
      • Jahangir Moini + 3 more
      • English
      • Paperback
        9 7 8 0 4 4 3 2 9 0 3 8 1
      • eBook
        9 7 8 0 4 4 3 2 9 0 3 9 8
      The Science of Pharmacology offers a detailed and contemporary exploration of medications, delving into the scientific principles behind drug actions and their therapeutic applications. It is an essential resource for students in pharmacology and pharmaceutical sciences, providing foundational knowledge on a wide range of topics. The book addresses the effects of drugs on various bodily systems, such as the nervous, respiratory, and cardiovascular systems, and also covers their impact on mental health and behavior. Beyond the core topics, the book also discusses special subjects like herbal medications and drug interactions.It includes valuable teaching materials, including test banks and quizzes, and offers comprehensive insights into toxicological treatments, making it an invaluable tool for both learning and teaching in the field.
    • Drug Metabolism in Diseases

      • 2nd Edition
      • December 1, 2025
      • Wen Xie
      • English
      • Hardback
        9 7 8 0 4 4 3 2 9 2 8 9 7
      • eBook
        9 7 8 0 4 4 3 2 9 2 9 0 3
      Drug Metabolism in Diseases: Leveraging Drug Metabolism and Disposition in Precision Medicine and Therapeutic Development, Second Edition provides essential knowledge for pharmaceutical scientists and biologists to understand the interplay between diseases and physiological conditions, impacting drug metabolism and its implications in personalized treatment. Expanded with six new chapters since the first edition, this updated book covers the latest scientific findings. Other important points include the book’s comprehensive reference on mutual effects between drug metabolism and diseases, implications in precision medicine, and therapeutic development. Pharmaceutical scientists, drug metabolism researchers, and research physicians will benefit from the expert insights provided.
    • Fighting Multidrug Resistance with Herbal Extracts, Essential Oils and Their Components

      • 2nd Edition
      • February 18, 2025
      • Mahendra Rai
      • English
      • Hardback
        9 7 8 0 4 4 3 2 9 0 4 4 2
      • eBook
        9 7 8 0 4 4 3 2 9 0 4 5 9
      Fighting Multidrug Resistance with Herbal Extracts, Essential Oils and their Components, Second Edition offers pharmaceutical and life sciences researchers an overview on the most relevant studies for fighting specific multidrug-resistant (MDR) microorganisms such as bacteria, protozoans, viruses, and fungi using natural products. This new edition expands the coverage of uses of traditional medicinal plants to against MDR, includes new chapters on the potential of plant-derived bioactive compounds for reversal of multidrug resistances, covers the use of flavonoids to combat microbes and cancer, and the use of nanoparticles as drug delivery vehicle.The need to combat multidrug-resistant microorganisms is an urgent one. This book provides important coverage of mechanism of action, the advantages and disadvantages of using herbal extracts, essential oils and their components, and more, to aid researchers in effective antimicrobial drug discovery.
    • Handbook of Melatonin-Based Therapy and its Applications

      • 1st Edition
      • October 1, 2025
      • Alejandro Romero Martínez + 2 more
      • English
      • Paperback
        9 7 8 0 4 4 3 3 0 2 4 0 4
      • eBook
        9 7 8 0 4 4 3 3 0 2 4 1 1
      Handbook of Melatonin-Based Therapy and its Applications provides pharmaceutical researchers and health professionals with a comprehensive reference on the applications of melatonin in the therapeutic setting. Succinct, meticulously organized, and expertly written, this book addresses all essential aspects. It starts with an overview of safe use of melatonin, translational aspects, and its prospection. The next section of the book covers a variety of clinical applications, including dosage, pharmacokinetics and pharmacodynamic profiles, toxicity, and principles of action. The chapters in this section cover applications to both adults and pediatric patients suffering from conditions like skin cancers, GI issues, psychiatric, hepatic and ocular conditions.This is a comprehensive resource for pharmaceutical scientists and health professionals involved in developing therapies and applying them to patients. Researchers in the fields of medicine, biology, neuroscience, and pharmacology conducting studies related to melatonin-based will benefit from insights into the latest research findings, clinical trials, and therapeutic approaches.
    • Pharmacological Targets in Metabolic Diseases

      • 1st Edition
      • September 3, 2025
      • Marcos Roberto de Oliveira
      • English
      • Paperback
        9 7 8 0 4 4 3 2 7 3 7 0 4
      • eBook
        9 7 8 0 4 4 3 2 7 3 7 1 1
      Pharmacological Targets in Metabolic Diseases: Challenges and Opportunities is a complete reference on possible drug development targets to be leveraged in therapeutic developments. Covering both signaling pathways and specific proteins, the book presents ways to modulate the molecular and cellular alterations observed in metabolic diseases and disorders through the application of new or classical drugs. The comprehensive coverage starts by providing an overview of metabolic diseases and disorders, biological alterations, and pharmacological targets. This section covers targets at both molecular, and subcellular and cellular levels. The next section in the book is focused on pharmaceutical targeting of organs, including a dedicated chapter to the gut-brain axis. Next comes a thorough review of the current advances in metabolic syndrome research. Section VI is focused on inborn errors of metabolism and is followed by a section devoted to natural molecules and their pharmacological potential to treat these conditions. The Editor introduces next a whole section dedicated to the role of the microbiota in metabolic diseases therapeutics. The following sections cover the impact of aging, nanotechnology, the environment, and finally diagnostic techniques in metabolic diseases and disorders. Pharmacological Targets in Metabolic Diseases: Challenges and Opportunities meet the needs of pharmacology researchers looking for a comprehensive and authoritative source of information on possible therapeutic targets to treat these conditions. Research physicians, nutritionists, pharmacists, and biologists can benefit from the detailed information provided at the different levels of targets identified to treat metabolic diseases and conditions.
    • Machine Learning in Drug Development: Part 2

      • 1st Edition
      • Volume 65
      • November 1, 2025
      • English
      • Hardback
        9 7 8 0 4 4 3 4 1 7 6 3 4
      • eBook
        9 7 8 0 4 4 3 4 1 7 6 4 1
      Machine Learning in Drug Development: Part Two, Volume 65 in the Annual Reports on Medicinal Chemistry series, highlights new advances in the field, with this new volume presenting interesting chapters written by an international board of authors. Chapters in this volume explore Transforming Modern Drug Discovery with Machine Learning – Applications in Ligand-based Drug Design, Optimizing Multi-Modal Drug Design Through Computational Pocket Mapping and Data Integration, Harnessing AI for Nucleic Acid Drug Discovery: Small Molecule Targeting DNA and RNA, AI-aided Drug Development for Protein Degraders: Design, Lead Identification, and Optimization, and more.Additional section delve into Artificial Intelligence in the Development of Antiviral Drugs – Progress and Applications, Artificial Intelligence for Drug Target Identification, and Machine Learning in Proteomic Biomarker Discovery
    • Progress in Medicinal Chemistry

      • 1st Edition
      • Volume 64
      • October 30, 2025
      • English
      • Hardback
        9 7 8 0 4 4 3 4 3 0 3 9 8
      • eBook
        9 7 8 0 4 4 3 4 3 0 4 0 4
      Progress in Medicinal Chemistry, Volume 64 highlights new advances in the field, with this new volume presenting interesting chapters written by an international board of authors.
    • Comprehensive Toxicology

      • 4th Edition
      • September 10, 2025
      • Charlene McQueen
      • English
      • Hardback
        9 7 8 0 3 2 3 9 5 4 8 8 4
      • eBook
        9 7 8 0 3 2 3 9 5 4 8 9 1
      Comprehensive Toxicology, Fourth Edition, Fifteen Volume Set continues the legacy that began with the first edition in 1997, serving as an indispensable reference for toxicology researchers. This edition focuses on understanding the mechanisms by which chemicals affect biological systems and cause adverse health effects. Edited by a distinguished editorial board and featuring 400 in-depth contributions from experts around the globe, this comprehensive work spans fifteen volumes and nearly 9,000 pages, covering all major organ systems and general principles of toxicology. This extensively revised edition includes around 30 new chapters on modern testing strategies and novel in vitro models, such as organ-on-a-chip systems.It also explores computational approaches, new risk and safety assessment methods, harmonization, artificial intelligence, and the microbiome. As the most authoritative resource in toxicology, it continues to support researchers, faculty, and students in toxicology, as well as professionals in medical, veterinary, food, environmental, chemical, and pharmaceutical industries and international regulatory agencies.
    • Machine Learning in Drug Development: Part 1

      • 1st Edition
      • Volume 64
      • October 15, 2025
      • English
      • Hardback
        9 7 8 0 4 4 3 4 1 3 6 5 0
      • eBook
        9 7 8 0 4 4 3 4 1 3 6 6 7
      Machine Learning in Drug Development: Part One, Volume 64 in the Annual Reports on Medicinal Chemistry series, highlights new advances in the field. Chapters in this release include Artificial Intelligence in Small Molecule and Nucleic Acid Research: A Review, AI-aided Drug Development for Protein Degraders: Design, Lead Identification, and Optimization, AI-aided Drug Development for Protein Degraders: Biology Validation, Disease-association, Drug Repurposing, Transforming Modern Drug Discovery with Machine Learning, Artificial Intelligence in the Development of Antiviral Drugs: Progress and Applications, Artificial Intelligence for Drug Target Identification, and Machine Learning in Proteomic Biomarker Discovery.